131233-67-5

Upstream product

• 100-39-0 benzyl bromide 
• 128387-20-2 L-1,2-O-isopropylidene-myo-inositol 
• 87-89-8 D-myo-inositol 
• 6195-66-0 rac-1,2,3,4-Tetra-O-benzyl-myo-inositol 
• 77-76-9 2,2-dimethoxy-propane 
• 6404-82-6 (+/-)-1,2-O-isopropylidene-myo-inositol 
• 111392-21-3 5,6-di-O-acetyl-1,2,3,4-tetra-O-benzyl-myo-inositol 
• 64656-21-9 5,6-di-O-allyl-1,2,3,4-tetra-O-benzyl-myo-inositol 
• 98906-26-4 (3aR,4R,5S,6S,7R,7aS)-5,6-Bis-allyloxy-4,7-bis-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxole 
• 131147-10-9 4,7,7-Trimethyl-3-oxo-2-oxa-bicyclo[2.2.1]heptane-1-carboxylic acid (3aS,4S,5R,6S,7S,7aS)-5,6,7-tris-benzyloxy-2,2-dimethyl-hexahydro-benzo[1,3]dioxol-4-yl ester 
• 38643-30-0 (±)-1,2:5,6-di-O-isopropylidene-myo-inositol 
• 155154-67-9 (1S,2R,3R,4S,5S,6R)-3,4-Bis-benzyloxy-5,6-bis-(4-methoxy-benzyloxy)-cyclohexane-1,2-diol 
• 13035-68-2 (±)-1,6-di-O-benzyl-2,3:4,5-di-O-cyclohexylidene-myo-inositol 
• 13035-66-0 (+/-)-3,4-di-O-benzyl-1,2-cyclohexylidene-myo-inositol 

Downstream Products

• 30485-14-4 (+/-)-3,4,5,6-Tetrakisbenzyloxy-cyclohex-2-enol 
• 6383-01-3 (+/-)-1-O-p-toluenesulfonyl-3,4,5,6-tetra-O-benzyl-myo-inositol 
• 129670-44-6 DL-2,3,4,5-Tetra-O-benzyl-1-deoxy-1-fluoro-6-O-tosyl-scyllo-inositol 
• 129163-26-4 (+/-)-3,4,5,6-tetra-O-benzyl-1-O-(p-methoxybenzyl)-myo-inositol 
• 141947-67-3 (+/-)-3,4,5,6-tetra-O-benzyl-2-deoxy-2-fluoro-1-O-(p-methoxybenzyl)-scyllo-inositol 
• 141947-68-4 (+/-)-3,4,5,6-tetra-O-benzyl-1-O-(p-methoxybenzyl)-myo-2-inosose 
• 30485-15-5 (+/-)-4,5,6-Tribenzyloxycyclohex-2-enon 
• 6383-02-4 2,4-bis(benzyloxy)-1-methoxybenzene 
• 6195-80-8 2,4-bis(benzyloxy)phenol 
• 261617-72-5 1,4-di-O-benzoyl-scyllo-inositol 2,3,5,6-tetrakis(diethyl phosphite) 
• 261617-70-3 1,2,3-tri-O-benzoyl-scyllo-inositol 4,5,6-tris(diethyl phosphonate) 
• 261621-52-7 1,2,3-tri-O-benzoyl-scyllo-inositol 

Relevant academic research and scientific papers

Synthesis and in vitro anticancer activity evaluation of novel bioreversible phosphate inositol derivatives

The chemistry and biology of phosphorylated inositols have become intense areas of research during the last two decades due to their involvement in various cellular signaling processes. However, the metabolic instability by phosphatases or kinases and poo

INOSITOL-BASED MOLECULAR TRANSPORTERS AND PROCESSES FOR THE PREPARATION THEREOF

Inositol derivatives in accordance with the present invention are effective in significantly enhancing the transportation of various therapeutic molecules across a biological membrane, which may include the plasma membrane, nuclear membrane or blood-brain barrier.

Convenient synthesis of 2-deoxy-scyllo-inosose and 2-deoxy-scyllo-inosamine: Two key intermediates on the biosynthetic pathway to aminoglycoside antibiotics

2-Deoxy-scyllo-inosose 1 and 2-deoxy-scyllo-inosamine 2 are two of the key intermediates on the biosynthetic pathway to 2-deoxystreptamine-containing aminoglycoside antibiotics. Convenient syntheses of 1, 2 and tritium-labelled 2 via stereoselective deoxy

Preparation of L-α-phosphatidyl-D-myo-inositol 3-phosphate (3-PIP) and 3,5-biphosphate (3,5-PIP2)

Practical, asymmetric total syntheses of the title phospholipids from a readily available myo-inositol derivative as well as short chain and cross-linkable aminoether analogues are described. (C) 2000 Elsevier Science Ltd. All rights reserved.

Synthesis of all possible regioisomers of scyllo-inositol phosphate

scyllo-Inositol is the all equatorial stereoisomer of myo-inositol. All possible 12 regioisomers of scyllo-inositol phosphate were synthesized for the first time via a scyllo-inositol benzoate intermediate, which was derived from a myo-inositol derivative. The stereoinversion of myo-inositol into scyllo-inositol was accomplished by Mitsunobu reaction of the vicinal cis- diol. The requisite intermediates, scyllo-inositol benzoates were obtained by benzoyl migration or random benzoylation, and phosphorylated to give scyllo- IP(n). (C) 1999 Elsevier Science Ltd.

Total synthesis of (+)-polyoxin J starting from myo-inositol

The total synthesis of the antifungal antibiotic, polyoxin J starting from myo-inositol is described; the two key components, were prepared from a pair of optically resolved myo-inositol derivatives , respectively, using a highly regioselective Baeyer-Vil

Synthesis of (±) 1,2-dideoxy-1,2-diamino-myo-inositol

Starting from myo-inositol, an isostere, diaminated in positions 1 and 2, was prepared. The key step of the synthesis was the simultaneous inversion of the dimesylate 6 with sodium azide leading to the global retention of the configuration.

The synthesis and resolution of (+/-)-1,4-di-O-benzyl-2,3-O-isopropylidene-myo-inositol

An improved procedure for the preparation of 1,2-O-isopropylidene-myo-inositol is described.Racemic 1,4-di-O-benzyl-2,3-O-isopropylidene-myo-inositol was prepared by tin-mediated benzylation of 1,2-O-isopropylidene-myo-inositol and resolved readily by cry

INVESTIGATIONS IN THE FIELD OF DERIVATIVES OF ASYMMETRICALLY SUBSTITUTED myo-INOSITOL. XXXVI. SEPARATION OF DIASTEREOMERIC CARBOHYDRATE DERIVATIVES OF myo-INOSITOL BY THE HPLC METHOD

The possibility has been shown of using the HPLC method for separating diastereomeric compounds of myo-inositol obtained under the conditions of the transesterification of racemic myo-inositol derivatives with D-mannose (ethyl orthoacetate).The optically active myo-inositol derivatives obtained can be used for the synthesis of myo-inositol phosphates with various structures.